Experimental Drugs News
Most Popular Experimental Drugs Story
Lilly readies Phase III Alzheimer's trial
Struggling to right itself after a long dry spell in new drug approvals, Eli Lilly is preparing to a launch a late-stage study of an experimental drug for Alzheimer's. LY450139 is expected to inhibit Read more...
Latest Headlines
- August 5, 2010
- March 31, 2008
- March 27, 2008
- January 9, 2008
- November 26, 2007
- September 27, 2007
- September 7, 2007
- August 8, 2007
- July 4, 2007
- January 9, 2007
- December 18, 2006
- December 11, 2006
- December 7, 2006
- November 12, 2006
- November 9, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
